Jane Street Group, LLC Bria Cell Therapeutics Corp. Call Options Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022
SELL
$5.91 - $10.14 $838,629 - $1.44 Million
-141,900 Reduced 63.78%
80,600 $817,000
Q4 2021

Feb 15, 2022
BUY
$7.1 - $10.61 $1.58 Million - $2.36 Million
222,500 New
222,500 $1.84 Million

Others Institutions Holding BCTX

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About BriaCell Therapeutics Corp.

BCTX Quotes by TradingView
  • Ticker BCTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,518,000
  • Market Cap $11.3M
  • Description
  • BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...
More about BCTX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email